The $80 million facility officially opened its doors Thursday, though patients started seeing providers there earlier this month.

Colorectal cancer, which develops in the colon or rectum, was among the most common early-onset gastrointestinal cancers in ...

Early-onset gastrointestinal (GI) cancers are rising at alarming rates worldwide and, in the U.S., are increasing faster than any other type of early-onset cancer, including breast cancer, according ...

SH-110, a liquid cancer treatment for glioma, earned orphan drug status from the FDA, helping patients who struggle to ...

Early-onset gastrointestinal (GI) cancers are rising at alarming rates worldwide and, in the U.S., are increasing faster than ...

Gastrointestinal cancers, which include colorectal, stomach and pancreatic cancer, are rising dramatically in younger adults.

The hunt for better treatments led researchers to reimagine targeted therapies. By 2022 they had developed one that linked Herceptin to another cancer-killing drug.